Urological surgery laser HPLASⅡ
HPLASⅡ operates dual wavelengths of 980nm and 1470nm running in parallel, So that it has the advantage that an optimal absorption is achieved in water and hemoglobin, which in turn means a high rate of ablation in co
Overview
HPLASⅡ operates dual wavelengths of 980nm and 1470nm running in parallel, So that it has the advantage that an optimal absorption is achieved in water and hemoglobin, which in turn means a high rate of ablation in combination with a good hemostatic (blood-staunching) effect.
The Dual laser could enable the ejaculation in internal structures of the prostate spared, so it is the very first time for laser method to prevent the so-called retrograde ejaculation, particularly for middle-aged men between 40 and 50 years old who may still have the wish to have children even if they are suffering from BPH.
The excellent hemostatic profile has a positive impact on the healing process: there is virtually no loss of blood during and after procedure, and the internal tissue is spared. The patient experiences relief following the treatment and no longer feels the constant and uncomfortable urge to urinate.
Advantage The new BPH probe with bare fibers contacts the tissue where it is needed, hence it could achieve an extremely high degree of ablation, Side-fire fiber is also optional, 12 inch color touch screen and user-friendly interface. Principle of treatment The treatment commences by inserting the Cystoscope containing our new BPH probe through the urethra. The head of the bare fiber is pushed out of the probe.
The operator steers the probe, rotating it to ablate the tissue in a circular motion. The funnel grows larger step by step and the BPH probe is withdrawn from the prostate at the end. Urine can once again flow off freely
